Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

Clinical trial NCT02023099 · COMPLETED

Trial details

NCT number: NCT02023099
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C Infection

Start date: 2013-12-01
Primary completion: 2014-10-01
Enrollment: 363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.